Effect of Tandem Autologous Stem Cell Transplant vs Single Transplant on Event-Free Survival in Patients With High-Risk Neuroblastoma | Zendy

Julie R. Park | Zendy; Susan G. Kreissman | Zendy; Wendy B. London | Zendy; Arlene Naranjo | Zendy; Susan L. Cohn | Zendy; Michael D. Hogarty | Zendy; Sheena C. Tenney | Zendy; Daphne A. HaasKogan | Zendy; Peter J. Shaw | Zendy; Jacqueline M. Kraveka | Zendy; Stephen S. Roberts | Zendy; James D. Geiger | Zendy; John J. Doski | Zendy; Stephan D. Voss | Zendy; John M. Maris | Zendy; Stephan A. Grupp | Zendy; Lisa Diller | Zendy

Open Access

Effect of Tandem Autologous Stem Cell Transplant vs Single Transplant on Event-Free Survival in Patients With High-Risk Neuroblastoma

Author(s) -

Julie R. Park,

Susan G. Kreissman,

Wendy B. London,

Arlene Naranjo,

Susan L. Cohn,

Michael D. Hogarty,

Sheena C. Tenney,

Daphne A. HaasKogan,

Peter J. Shaw,

Jacqueline M. Kraveka,

Stephen S. Roberts,

James D. Geiger,

John J. Doski,

Stephan D. Voss,

John M. Maris,

Stephan A. Grupp,

Lisa Diller

Publication year - 2019

Publication title -

jama

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.688

H-Index - 680

eISSN - 1538-3598

pISSN - 0098-7484

DOI - 10.1001/jama.2019.11642

Subject(s) - medicine , neuroblastoma , stem cell , oncology , transplantation , event (particle physics) , surgery , cell culture , genetics , physics , quantum mechanics , biology

Induction chemotherapy followed by high-dose therapy with autologous stem cell transplant and subsequent antidisialoganglioside antibody immunotherapy is standard of care for patients with high-risk neuroblastoma, but survival rate among these patients remains low.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research